This regulation is achieved via the FXR/LXR axis-mediated inhibition of autophagy, which is crucial in the crosstalk between hepatic stellate cells (HSCs) and macrophages, highlighting the complex interdependencies and therapeutic potential of the jointly triggered FXR and LXR pathways in liver disease management97. The gene discussed is NR1H4; the disease is liver disorder.